Related Experiment Video
Updated: Jan 18, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
The Association Between Obesity and COVID-19 Severity in Children Differed Between SARS-CoV-2 Variants: A
Yanshan Zhu1, Petra Zimmermann2,3,4, Daniel K Yeoh5,6
1From the School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Insights
Obesity increased severe COVID-19 risk in children during earlier SARS-CoV-2 variants. This association was not observed during the Omicron wave, even in unvaccinated children, indicating changing disease dynamics.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- Obesity posed a significant risk for severe COVID-19 in children during the ancestral and Delta variant waves.
- The impact of obesity on pediatric COVID-19 severity during the Omicron variant surge remained undetermined.
Purpose of the Study:
- To investigate the association between childhood obesity and COVID-19 severity during different SARS-CoV-2 variant waves.
- To determine if vaccination status influenced the relationship between obesity and respiratory support needs.
Main Methods:
- A multicenter, observational study analyzed hospitalized children and adolescents with confirmed SARS-CoV-2 infection.
- Data spanned three periods: ancestral strain (T1), pre-Omicron variants (T2), and Omicron (T3).
- The primary outcome measured was the requirement for respiratory support (supplemental oxygen or ventilation).
Main Results:
- Obesity was linked to increased respiratory support needs during T1 (RR 3.45) and T2 (RR 3.24).
- This association was not significant during the Omicron wave (T3) (RR 3.08).
- Findings persisted in unvaccinated children, suggesting vaccination did not explain the diminished association.
Conclusions:
- Childhood obesity was a risk factor for severe COVID-19 during ancestral and pre-Omicron waves.
- The association between obesity and severe COVID-19 was lost during the Omicron wave.
- This shift highlights evolving SARS-CoV-2 variant impacts on pediatric populations, irrespective of vaccination status.
Background:
Obesity was a risk factor for severe COVID-19 in children during early outbreaks of ancestral SARS-CoV-2 and the Delta variant. However, the relationship between obesity and COVID-19 severity during the Omicron wave remains unclear.
Methods:
This multicenter, observational study included polymerase chain r eaction-confirmed SARS-CoV-2-infected children and adolescents from Australia, Brazil, Italy, Portugal, Switzerland, Thailand, the United Kingdom and the United States hospitalized between January 1, 2020, and March 31, 2022. Data were collected across 3 time periods representing dominant SARS-CoV-2 variants: the ancestral strain (T1), pre-Omicron variants (Alpha and Delta; T2) and Omicron (T3). The primary outcome was the need for supplemental oxygen therapy and/or ventilatory support (respiratory support).
Results:
This study included 6176 hospitalized children and adolescents of 2 to <18 years of age. The median age was 11.0 (interquartile range, 6.0-14.0) years, and 2989 (48.4%) were female. Obesity status was available for 5460 (88.4%), of whom 213 (3.9%) met the criteria for having obesity. Obesity was positively associated with the need for respiratory support during T1 [risk ratio (RR), 3.45 (95% CI: 2.02-5.88)] and T2 [RR, 3.24 (95% CI: 1.57-6.67], but this association was lost during T3 [RR, 3.08 (95% CI: 0.85-11.15)]. These findings were similar for unvaccinated children.
Conclusions:
Obesity was associated with more severe COVID-19 during the ancestral and pre-Omicron waves but not during the Omicron wave. Importantly, the same phenomenon was observed in unvaccinated children, suggesting that differences in vaccination did not account for the observed changes in the need for respiratory support over time.
Related Concept Videos
Obesity
Bias in Epidemiological Studies
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Causality in Epidemiology

